Sign In
to Vote &
Create Storyboards.
 
A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42% The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard